Effect of non-absorbable antibiotic, rifaximin in patients with irritable bowel syndrome: A single-center randomized controlled study

Background: Irritable bowel syndrome (IBS), most common functional bowel disease, does not have a definite treatment. Studies revealed the involvement of bacterial overgrowth for its pathology. The aim of this study is to evaluate the effect of a non-absorbable antibiotic. Aims and Objectives: The...

Descripció completa

Dades bibliogràfiques

Autors principals:	Bhagyalekshmi N, Ramesh M, Prathibha V K, J Xavier Ignatius
Format:	Artigo
Idioma:	Inglês
Publicat:	Eldaghayes Publisher 2018-06-01
Col·lecció:	National Journal of Physiology, Pharmacy and Pharmacology
Matèries:	irritable bowel syndrome; rifaximin; non-absorbable antibiotic; randomized controlled study
Accés en línia:	http://www.ejmanager.com/fulltextpdf.php?mno=285114
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!